Compound information
- Natural Products
- ZC2235291
- Molecular Formula
- C16H16Cl2N2O3S
- Molecular Weight
- 386.025868732 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-[4-chloro-3-[ethyl(phenyl)sulfamoyl]phenyl]acetamide
- InChI
- InChI=1S/C16H16Cl2N2O3S/c1-2-20(13-6-4-3-5-7-13)24(22,23)15-10-12(8-9-14(15)18)19-16(21)11-17/h3-10H,2,11H2,1H3,(H,19,21)
- InChI Key
- NKSONIUMPUUEIL-UHFFFAOYSA-N
- SMILES
- CCN(c1ccccc1)S(=O)(=O)c1cc(NC(=O)CCl)ccc1Cl
- Source
- ZINC000003885220
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 3.601 |
LogS | -5.107 | LogD | 3.122 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.057 | Pgp substrate | 0.001 |
HIA | 0.968 | F20 % | 0.992 |
F30 % | 0.975 | Caco-2 | -5.042 |
MDCK | -4.816 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.118 | PPB | 98.825 |
VD | 0.439 | Fu | 1.897 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.922 | CYP1A2 substrate | 0.706 |
CYP2A6 substrate | 0.742 | CYP2B6 substrate | 0.647 |
CYP2C19 inhibitor | 0.994 | CYP2C19 substrate | 0.952 |
CYP2C8 substrate | 0.866 | CYP2C9 inhibitor | 0.994 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.97 |
CYP2D6 substrate | 0.729 | CYP2E1 substrate | 0.626 |
CYP3A4 inhibitor | 0.887 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.609 | CL | 1.37 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.014 | Hepatotoxicity | 0.998 |
Mutagenicity | 0.05 | Rat Oral Acute Toxicity | 0.047 |
FDAMDD | 0.107 | Skin Sensitization | 0.972 |
Carcinogenicity | 0.031 | Eye Corrosion | 0.007 |
Eye Irritation | 0.044 | Respiratory Toxicity | 0.287 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.04 | IGC50 | 4.817 |
LC50FM | 4.788 | LC50DM | 4.322 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.164 | NR-AR-LBD | 0.514 |
NR-AhR | 0.637 | NR-Aromatase | 0.542 |
NR-ER | 0.519 | NR-ER-LBD | 0.523 |
NR-PPAR-gamma | 0.916 | SR-ARE | 0.966 |
SR-ATAD5 | 0.444 | SR-HSE | 0.142 |
SR-MMP | 0.952 | SR-p53 | 0.825 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.